Physician profile
Eric J Beadle
NPI 1164484218
$13,492.80
in general payments reported to CMS, 2019-2025
52 companies · $2,345 in 2025
The $2,345 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,192 · 2020: $726 · 2021: $1,694 · 2022: $2,483 · 2023: $2,421 · 2024: $1,632 · 2025: $2,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,398.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,767.15 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,349.60 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $1,344.45 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Lilly USA, LLC | $1,180.84 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $1,096.78 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Pfizer INC. | $833.56 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $793.80 | 2019-2025 | Jardiance |
| Abbott Laboratories | $667.93 | 2021-2025 | Freestyle Libre, Jot Dx |
| Amarin Pharma, INC. | $328.97 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $325.44 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $310.20 | 2019-2025 | Belsomra, Segluromet, Steglatro |
| Allergan, INC. | $288.16 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $278.29 | 2019-2022 | |
| Astellas Pharma US INC | $276.31 | 2019-2025 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $264.88 | 2019-2025 | Xifaxan |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Beadle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.